Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications

Bibliographic Details
Title: Covalent organic framework nanomedicines: Biocompatibility for advanced nanocarriers and cancer theranostics applications
Authors: Nem Singh, Jungryun Kim, Jaewon Kim, Kyungwoo Lee, Zehra Zunbul, Injun Lee, Eunji Kim, Sung-Gil Chi, Jong Seung Kim
Source: Bioactive Materials, Vol 21, Iss , Pp 358-380 (2023)
Publisher Information: KeAi Communications Co., Ltd., 2023.
Publication Year: 2023
Collection: LCC:Materials of engineering and construction. Mechanics of materials
LCC:Biology (General)
Subject Terms: Materials of engineering and construction. Mechanics of materials, TA401-492, Biology (General), QH301-705.5
More Details: Nanomedicines for drug delivery and imaging-guided cancer therapy is a rapidly growing research area. The unique properties of nanomedicines have a massive potential in solving longstanding challenges of existing cancer drugs, such as poor localization at the tumor site, high drug doses and toxicity, recurrence, and poor immune response. However, inadequate biocompatibility restricts their potential in clinical translation. Therefore, advanced nanomaterials with high biocompatibility and enhanced therapeutic efficiency are highly desired to fast-track the clinical translation of nanomedicines. Intrinsic properties of nanoscale covalent organic frameworks (nCOFs), such as suitable size, modular pore geometry and porosity, and straightforward post-synthetic modification via simple organic transformations, make them incredibly attractive for future nanomedicines. The ability of COFs to disintegrate in a slightly acidic tumor microenvironment also gives them a competitive advantage in targeted delivery. This review summarizes recently published applications of COFs in drug delivery, photo-immuno therapy, sonodynamic therapy, photothermal therapy, chemotherapy, pyroptosis, and combination therapy. Herein we mainly focused on modifications of COFs to enhance their biocompatibility, efficacy and potential clinical translation. This review will provide the fundamental knowledge in designing biocompatible nCOFs-based nanomedicines and will help in the rapid development of cancer drug carriers and theranostics.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2452-199X
Relation: http://www.sciencedirect.com/science/article/pii/S2452199X22003590; https://doaj.org/toc/2452-199X
DOI: 10.1016/j.bioactmat.2022.08.016
Access URL: https://doaj.org/article/2d46ed53a67a45a8ba551de641b2b49f
Accession Number: edsdoj.2d46ed53a67a45a8ba551de641b2b49f
Database: Directory of Open Access Journals
More Details
ISSN:2452199X
DOI:10.1016/j.bioactmat.2022.08.016
Published in:Bioactive Materials
Language:English